Edwards Lifesciences Corporation · NYSE:EW
The Vanguard Group reported a 11.72% stake in Edwards Lifesciences Corporation (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 30, 2025
The Vanguard Group reported a 11.72% stake in Edwards Lifesciences Corporation, 69,131,602 shares, as a passive investor on Dec 31, 2024. Filed Jan 30, 2025 (Schedule 13G/A).
- Stake
- 11.72%
- Shares
- 69,131,602
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 11.72% | 69,131,602 |
Source
Related
- Edwards Lifesciences Corporation
- The Vanguard Group
- Edwards Lifesciences Corporation shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Lippis Daniel J. · Oct 8, 2026
- Form 4 · Markowitz Wayne · Sep 14, 2026
- Form 4 · Dahl Andrew M. · Sep 14, 2026
- Form 4 · Lippis Daniel J. · Sep 11, 2026
- Form 4 · Chopra Daveen · Sep 11, 2026